1000/1000
Hot
Most Recent
Skeletal muscle dysfunction is frequently associated with chronic obstructive pulmonary disease (COPD), which is characterized by a permanent airflow limitation, with a worsening respiratory disorder during disease evolution. COPD is a progressive lung disease, characterized by an irreversible airflow limitation. In COPD, the pathophysiological changes related to the chronic inflammatory state affect oxidant–antioxidant balance, which is one of the main mechanisms accompanying extra-pulmonary comorbidity such as muscle wasting. Muscle impairment is characterized by alterations on muscle fiber architecture, contractile protein integrity, and mitochondrial dysfunction. Vitamin D deficiency affects oxidative stress and mitochondrial function influencing disease course through an effect on muscle function in COPD patients.
Experimental Data | Model | Sample Size | Tissue | Approach | Reference |
---|---|---|---|---|---|
Evaluation of oxygen consumption, biogenesis, dynamics, and nuclear genes encoding variations. | Human | // | Muscle biopsies. Primary human skeletal muscle cells. |
Supplementation of 1α,25-Dihydroxyvitamin D3 (10-8 M) for 48 h. VDR expression in human muscle cells and skeletal muscle homogenates. Effect of 1α,25(OH)2D mitochondrial oxygen consumption and in expression of: mitochondrial proteins that alter mitochondrial fusion; proteins associated with mitochondrial fission; phosphorylated pyruvate dehydrogenase and pyruvate dehydrogenase kinase 4; genes encoding mitochondrial proteins; and genes encoding cellular signaling and growth-regulatory pathways in adult human skeletal muscle cells. Knockdown of VDR with silencing RNA in skeletal muscle cells to detect the effects of 1α,25(OH)2D3 on OCR. |
[45] |
Assessment of oxidative and nitrosative stress parameters. | Rat | // | Fasting blood samples analysis. C2C12 cell culture. | Supplementation of 1,25(OH)2D3 (1 nM and 10 nM) for 24 h. Effect of VDD in muscle oxidative stress in a rat model. Pre/post treatment of C2C12 muscle cells with vitamin D offers protection against oxidative stress induced muscle proteolysis. VDD increase in activities of the glutathione-dependent enzymes and decrease in SOD and catalase enzymes in the rat muscle. Pre/post treatment of C2C12 muscle cells with vitamin D correct total protein degradation, 20S proteasomal enzyme activity, muscle atrophy gene markers and expression of proteasome subunit genes induced by oxidative stress. |
[51] |
Serum and lung tissue analysis. | Human | 180 COPD patients | Human lung tissues and serum samples of COPD. | Level of pulmonary VDR-positive nuclei between COPD patients and control subjects Correlations of pulmonary function with pulmonary DJ-1, Nrf-2 and VDR in COPD patients. |
[57] |
Antioxidant and antiaging effects of 1,25Dihydroxyvitamin D by activation of Nrf2-antioxidant signaling and inactivation of p16/p53-senescence signaling. | Mouse | 120 | Skin, lung, liver, kidney, and spleen. | Two different supplementation: thrice weekly of 2.2 IU vitamin D/g or 1,25(OH)2D3 (1 μg/kg) until death. Effects of a high-calcium/phosphate diet, of 1,25(OH)2D3, and of antioxidant supplementation on lifespan, body weight, skin morphology; on oxidative stress, DNA damage, protein expression of oncogenes and tumor suppressive genes; and on cell proliferation and senescence in 1α(OH)ase−/− mice. |
[58] |
Improvement in parameters of mitochondrial function in vitamin-D-deficient individuals after vitamin D supplementation. | Human | 12 subjects with severe vitamin D deficiency | Serum samples | Effect of cholecalciferol therapy (20 000 IU supplementation on alternate days for 10–12 weeks) in muscle mitochondrial maximal oxidative phosphorylation after exercise in symptomatic, vitamin-D-deficient individuals. | [60] |
FOXO1 activation in the skeletal muscle of global VDR-null mice. | Mouse | VDR−/− mice administered a diet enriched with calcium and phosphorus; SMVDR−/− mice generated by crossing VDRloxp/loxp mice with mice with muscle-specific Cre recombinase expression under the control of the myosin light chain 1f (MLC 1f) genomic locus; C2C12 muscle cells. | Treatment of C2C12 muscle cells with 1,25-dihydroxyvitamin D (100 nM for 48 h) to detect FOXO1 expression, nuclear translocation, and activity. Evaluation of FOXO1 activation in knockdown VDR mice. | [61] | |
Effect of vitamin D supplementation on oxidative stress. | Mouse | Eight mice for each experimental group. | Adipocyte cell culture model | Supplementation of cholecalciferol (67 IU VD/kg daily for last 8 weeks) to detect the effects of 1,25(OH)2D3 supplementation in NOX4, Nrf2 SIRT-1 expression, ROS production, NF-κB and AMPK phosphorylation. | [62] |